Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment

• Status: Not yet recruiting
• Trial end date: 2026-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: UMC Utrecht
• Treatments: Progesterone

Criteria

Inclusion Criteria:

• Couples starting IUI with Mild Ovarian HyperStimulation (MOH), with the intend to receive this treatment for at least six months.

• Diagnosis of unexplained (primary or secondary) infertility

• Hunault <30% (or >30%, after an expectant management period of at least 6 additional months).

• Females aged >18 years with regular menstrual cycle.

• Total mobile sperm count (VCM) >10 million.

Exclusion cirteria:

• Cycle irregularities

• Male factor infertility